Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
Guardado en:
Autores principales: | Alexander Zarbock, Lakhmir Chawla, Rinaldo Bellomo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fbde3e1be2244cbbc64f09f1ad0a3e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The obesity paradox and hypoglycemia in critically ill patients
por: Drago Plečko, et al.
Publicado: (2021) -
Association between longer duration of citrate accumulation and 90-day mortality of acute-on-chronic liver failure
por: Ming Wang, et al.
Publicado: (2021) -
Epidemiology of Bleeding in Critically Ill Children With an Underlying Oncologic Diagnosis
por: Juliana Romano, MD, et al.
Publicado: (2021) -
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients
por: Douglas D. Fraser, MD, PhD, et al.
Publicado: (2020) -
Experience With Cardiology-Oriented Outcomes in Critically Ill Patients With Coronavirus Disease 2019
por: Randi Connor-Schuler, MD, et al.
Publicado: (2020)